ABUS·03879J100·US·equity·Healthcare - Biotechnology-Activist
ABUS (ARBUTUS BIOPHARMA CORP) is held by 100 institutional investors as of Q1 2026. Largest holders: MORGAN STANLEY ($116.5M), BlackRock, Inc. ($58.4M), STATE STREET CORP ($28.5M). Net institutional sentiment: Mixed.
See how ABUS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer